Fusion protein mTSLPR-Ig regulates CD11c~+ cells and improve the inflammatory reactions in a mouse model of asthma

ZHANG Fang,SHI Yi,LI Zi-ling,HU Bo,SONG Yong
2011-01-01
Abstract:Thymic stromal lymphopoietin(TSLP) activates CD11c+ through the combination with its receptor(TSLPR) on the surface of CD11c+,thus resulting in Th1/Th2 imbalance in asthma.To study the feasibility of fusion protein mTSLPR-Ig constituted by the extracellular segment of mouse TSLPR and mouse Fc of Ig,to reverse Th1/Th2 imbalance and to improve airway inflammation in asthma mouse in order to explore the mechanism of mTSLPR-Ig inducing immune tolerance in asthma by regulating CD11c+,ovalbumin(OVA) was injected intraperitoneally and challenged with aerosol inhalation in BALB/c mice to establish an animal models of asthma.Before the OVA challenging,mTSLPR-Ig were infused intranasally in mice.The total number of cells in BALF,eosinophils and lymphocytes were counted with light microscope,and the levels of cytokines IL-4,IL-5,IFN-γ and IL-10 in BALF were evaluated with ELISA assay.The inflammatory reactions of lung was observed with HE staining.After the preparation of lungs tissues into cell suspension,the expression of co-stimulatory molecules CD80,CD86 and CD40 on the surface of CD11c+ were detected with FCM assay.It was demonstrated that the airway inflammation,the counts of total cell and eosinophil,and IL-4,IL-5 level in BALF were significantly reduced in mTSLPR-Ig treated mice,while IL-10,IFN-γ level were enhanced.TSLPR-mIg treatment resulted in the reduction of CD80,CD86 and CD40 expression significantly.From these observation,it is evident that mTSLPR-Ig can inhibit allergic lung inflammation and Th1/Th2 imbalance,which may be related to the expression suppression of the co-stimulatory molecules on pulmonary CD11c+ by fusion protein mTSLPR-Ig,indicating that this fusion protein may have potential clinical value for the treatment of asthma,and providing a new way to treat this allergic disease.
What problem does this paper attempt to address?